Meeting
2012 Breast Cancer Symposium
Response and long-term outcomes after neoadjuvant chemotherapy: Pooled dataset of patients stratified by molecular subtyping by MammaPrint and BluePrint.
Authors
Stefan Gluck
University of Miami Sylvester Comprehensive Cancer
Stefan Gluck , Femke De Snoo , Justine Peeters , George Somlo , Lisette Stork-Sloots , Laura van 't Veer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A
Track
Risk Assessment, Prevention, Detection, and Screening
Sub Track
Genomics
Citation
J Clin Oncol 30, 2012 (suppl 27; abstr 10)
DOI
10.1200/jco.2012.30.27_suppl.10
Abstract #
10
Poster Bd #
B4
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Response and long-term outcomes after neoadjuvant chemotherapy: Pooled dataset of patients stratified by molecular subtyping by MammaPrint and BluePrint.
First Author: Stefan Gluck
Poster
2022 ASCO Annual Meeting
Identification of transcriptional changes with MammaPrint and BluePrint in early-stage breast cancer after neoadjuvant chemotherapy.
First Author: Alice P. Chung
Poster
2013 Breast Cancer Symposium
Can Oncotype DX recurrence score (RS) be used in Luminal A and Luminal B breast cancer patients (pts) to predict the likely benefit of chemotherapy? A retrospective unicentric study in Spanish population.
First Author: Laura G. Estevez
Poster
2012 Breast Cancer Symposium
Molecular subtyping using MammaPrint and BluePrint as an outcome predictor in U.S. breast cancer (BC) patients.
First Author: Katharine Yao